via University of South Australia
University of South Australia researchers are a step closer to finding a new biomarker for osteoarthritis, a painful condition which affects more than two million Australians and costs the country an estimated $23 billion a year.
Using new state-of-the-art imaging techniques to identify signs of osteoarthritis (OA), UniSA scientists are learning more about changes at the molecular level which indicate the severity of cartilage damage.
A study led by PhD student Olivia Lee and her supervisor Associate Professor Paul Anderson using mass spectrometry imaging (MSI) has mapped complex sugars on OA cartilage, showing different sugars are associated with damaged tissue compared to healthy tissue.
The finding will potentially help overcome one of the main challenges of osteoarthritis research – identifying why cartilage degrades at different rates in the body.
“Despite its prevalence in the community, there is a lot about osteoarthritis that we don’t understand,” Prof Anderson says.
“It is one of the most common degenerative joint diseases, yet there are limited diagnostic tools, few treatment options and no cure.”
Existing OA biomarkers are still largely focused on bodily fluids which are neither reliable nor sensitive enough to map all the changes in cartilage damage.
By understanding the biomolecular structure at the tissue level and how the joint tissues interact in the early stages of osteoarthritis, UniSA researchers say any molecular changes could be targeted to help slow the progression of the disease with appropriate medication or treatment.
Osteoarthritis affects an estimated 2.2 million Australians and more than 300 million people worldwide, with those aged over 45 most at risk. Being female, overweight, and having existing joint injuries increases the risk of getting OA.
In Australia, $3.75 million is spent on joint replacements alone for osteoarthritis patients each year, and other indirect costs related to lost work productivity and loss of wellbeing are estimated to be more than $23 billion a year.
In a recent paper published in the International Journal of Molecular Sciences, Lee and her colleagues from UniSA’s Musculoskeletal Biology Research Laboratory and the Future Industries Institute explore how advances in mass spectrometry imaging (MSI) to detect OA are promising.
“To date, diagnosing osteoarthritis has relied heavily on x-rays or MRI, but these provide limited information and don’t detect biomolecular changes that signal cartilage and bone abnormalities,” Lee says.
“By contrast, alternative imaging methods such as MSI can identify specific molecules and organic compounds in the tissue section.”
MSI has already demonstrated its strengths in identifying biomarkers for different types of cancer, and UniSA researchers are hopeful it can achieve the same for early diagnosis of osteoarthritis.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Mohawk is a transcription factor that promotes meniscus cell phenotype and tissue repair and reduces osteoarthritis severityon October 28, 2020 at 11:19 am
1 Department of Molecular Medicine, Scripps Research, La Jolla, CA 92037, USA. 2 Shiley Center for Orthopaedic Research and Education at Scripps Clinic, La Jolla, CA 92037, USA. 3 Department of ...
- Dr. Roach: Nodes on finger joints are due to osteoarthritison October 20, 2020 at 9:06 pm
Heberden’s and Bouchard’s nodes are manifestations of osteoarthritis in the hand. A quick anatomy lesson: Your second, third, fourth and fifth fingers all have three phalanges, the small bones of the ...
- Impact Of Consuming NZ Greenshell™ Mussels In Combatting Early Stages Of Osteoarthritison October 20, 2020 at 5:51 pm
Value Nutrition National Science Challenge focuses on the impact of consuming NZ Greenshell™ mussels in combatting early stages of osteoarthritis The High-Value Nutrition (HVN) National Science ...
- Eating NZ Greenshell mussels may help in combatting early stages of osteoarthritison October 20, 2020 at 3:18 pm
Value Nutrition National Science Challenge focuses on the impact of consuming NZ Greenshell™ mussels in combatting early stages of osteoarthritis ...
- Galapagos Knee Osteoarthritis Data, And Other News: The Good, Bad And Ugly Of Biopharmaon October 18, 2020 at 3:21 am
Galapagos announces topline data from knee osteoarthritis trial. Evelo provides updates for EDP1815 in Atopic Dermatitis and Psoriasis trials.
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Neutrophil-mediated carbamylation promotes articular damage in rheumatoid arthritison October 28, 2020 at 3:09 pm
Rheumatoid arthritis (RA) is an autoimmune condition that affects ... Despite its clear potential as a useful biomarker of poor prognosis in RA subjects, the source of individual carbamylated ...
- Study provides novel biomarkers for predicting rheumatoid arthritis patient responsiveness to DMARDson October 27, 2020 at 5:08 am
A new study led by researchers at Queen Mary University of London provides potential novel biomarkers for predicting patient responsiveness to disease-modifying anti-rheumatic drugs (DMARDs).
- New research predicts whether rheumatoid arthritis patients will respond to treatmenton October 27, 2020 at 3:44 am
A new study led by researchers at Queen Mary University of London provides potential novel biomarkers for predicting patient responsiveness to disease modifying anti-rheumatic drugs (DMARDs).
- New Research Finds If Rheumatoid Arthritis Patients Respond to Treatmenton October 27, 2020 at 3:19 am
Potential novel biomarkers helps in predicting the patient responsiveness to disease modifying anti-rheumatic drugs (DMARDs), according to the team of researchers at Queen Mary University of London.
- Study Shows We Might Be Thinking About Joint Injuries in The Wrong Wayon October 23, 2020 at 4:30 pm
Joint injuries can often lead to joint disease in both humans and other animals, but a new study looking at a particular biological lubricant suggests we might have to rethink how these diseases ...